Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Specialty Laboratories (NYSE:SP)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider
Location
2211 Michigan Avenue
Santa Monica, CA 90404
Phone: (310) 828-6543
Fax: (310) 828-6634
Email: investor.relations@specialtylabs.com
Employees (last reported count): 799
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Healthcare Facilities
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 72%
·Over the last 6 months:
 · one insider buy; 5,000  shares
 · 4 insider sells; 192.0K shares
  (1.2% of insider shares)
·Institutional: 29% (104% of float)
(114 institutions)
·Net Inst. Buying: 135.0K shares (+2.12%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Specialty Laboratories, Inc. is a research-based clinical laboratory predominantly focused on developing and performing esoteric clinical laboratory tests, which the Company refers to as assays. The Company offers more than 3,500 esoteric assays, many of which have been developed through its internal research and development efforts. Esoteric assays are complex, comprehensive or unique tests used to diagnose, evaluate and monitor patients. These assays are often performed on sophisticated instruments by highly skilled personnel, and are therefore offered by a limited number of clinical laboratories. Two of the Company's thousands of esoteric assays include GenotypR, its assays for predicting resistance to HIV, and ANAlyzer, its assays used to help diagnose complex autoimmune disorders. The Company performs all of its testing services at its laboratory facility in Santa Monica, California.
More from Market Guide: Expanded Business Description

Financial Summary
Specialty Laboratories Inc. is a research-based clinical laboratory focused predominantly on developing and performing esoteric clinical laboratory tests. For the six months ended 6/30/01, revenues increased 20% to $89 million. Net income increased 57% to $6.6 million. Revenues reflect increased accessions due to a growth in existing core business and the acquisition of the assets of BBI Clinical Laboratories. Net income also reflects improved efficiencies.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

James Peter, M.D., Ph.D, 67
Chairman, CEO
$900K
Paul Beyer, 41
Pres, COO, Director
543K
Frank Spina, 46
CFO
245K
Shoji Maruyama, 60
Sr. VP
--  
Bart Thielen, 36
VP-Fin., Treasurer
231K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:SPAs of 31-Aug-2001
Price and Volume
52-Week Low
on 13-Mar-2001
$16.75 
Recent Price$31.60 
52-Week High
on 6-June-2001
$47.00 
Daily Volume (3-month avg)121.5K
Daily Volume (10-day avg)64.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
26-Week Change+20.2%
26-Week Change
relative to S&P500
+30.9%
Share-Related Items
Market Capitalization$673.8M
Shares Outstanding21.3M
Float6.00M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$5.77 
Earnings (ttm)$0.55 
Earnings (mrq)$0.15 
Sales (ttm)$8.45 
Cash (mrq)$2.46 
Valuation Ratios
Price/Book (mrq)5.48 
Price/Earnings (ttm)57.04 
Price/Sales (ttm)3.74 
Income Statements
Sales (ttm)$168.1M
EBITDA (ttm)$18.7M
Income available to common (ttm)$11.1M
Profitability
Profit Margin (ttm)6.6%
Operating Margin (ttm)10.2%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)8.75%
Return on Equity (ttm)11.77%
Financial Strength
Current Ratio (mrq)3.63 
Debt/Equity (mrq)0 
Total Cash (mrq)$52.4M
Short Interest
As of 8-Aug-2001
Shares Short215.0K
Percent of Float3.6%
Shares Short
(Prior Month)
226.0K
Short Ratio2.34 
Daily Volume92.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.